Clinical Trials Logo
  1. Home
  2. Fibrillation, Atrial
  3. NCT04761315

Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)

Fibrillation, Atrial Clinical Trial

Official title:
Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)

Clinical Trial Summary

The presence of interatrial block (IAB) is associated with the development of atrial fibrillation (AF). The aim of this study was to determine whether P-wave duration and presence of IAB before the implantation of a cardiac implantable electronic device (CIED) are associated with the presence of atrial high rate episodes (AHRE), during long-term follow-up.

Clinical Trial Description

The presence of interatrial block (IAB) is associated with the development of atrial fibrillation (AF). The aim of this study was to determine whether P-wave duration and presence of IAB before the implantation of a cardiac implantable electronic device (CIED) are associated with the presence of atrial high rate episodes (AHRE), during long-term follow-up. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04761315
Study type Observational [Patient Registry]
Source Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Contact
Status Completed
Phase
Start date January 1, 2015
Completion date December 31, 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT00244725 - Odiparcil For The Prevention Of Venous Thromboembolism Phase 2
Terminated NCT00437242 - Odiparcil QT Definitive Study Phase 1
Completed NCT00402363 - Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation Phase 3
Completed NCT00240643 - Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke Phase 2
Completed NCT00041496 - Prevention Of Recurrence Of Atrial Fibrillation Phase 2
Withdrawn NCT03401931 - Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers
Completed NCT04537507 - Atrial Fibrillation and Non-obstructive Coronary Lesions
Not yet recruiting NCT06200311 - Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men N/A
Completed NCT00911300 - Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm Phase 2